期刊文献+

胃癌单抗MGd1的噬菌体呈现型ScFv的制备 被引量:3

Generation of phage-displayed single chain variable fragments of monoclonal antibody MGd1 recognizing gastric carcinoma
下载PDF
导出
摘要 目的制备胃癌单抗 MGd1的单链可变区片段 (single chain variable fragm ent,Sc Fv) ,为胃癌体内诊疗研究提供候选靶向载体分子。方法从 MGd1杂交瘤分离 m RNA,RT- PCR分别扩增抗体重、轻链可变区基因 (VH和 VL DNA) ,二者经 linker DNA连接形成 Sc Fv DNA。将 Sc Fv DNA与载体 p CANTAB5 E的连接产物转化于大肠杆菌 TG1,经 M13KO7感染后 ,获得重组噬菌体抗体 Sc Fv。以高表达 MGd1结合抗原的细胞株 KATO 对重组噬菌体抗体 Sc Fv进行两轮筛选后 ,随机挑取克隆经 EL ISA筛选 MGd1Sc Fv单克隆 ,并对其结合抗原的能力进行鉴定。结果 VH、VL 和 Sc Fv DNA分别约为 340、32 0和 75 0 bp。经两轮亲和筛选后 ,在随机筛检的 30个克隆中得到 12个噬菌体呈现型 MGd1Sc Fv单克隆 ,其中结合抗原能力强的克隆有 5个。结论用噬菌体呈现技术成功地获得了单抗 MGd1的 Sc Fv,为拓展该抗体的应用范围奠定了基础。 ObjectiveTo provide possible tumor targeting vehicle for in vivo study on diagnosis and treatment of gastric carcinoma by generating single chain variable fragments (ScFv) of monoclonal antibody MGd1 recognizing the carcinoma. Methods mRNA was isolated from the hybridoma cell line producing monoclonal antibody MGd1. Heavy and light chain genes were amplified separately and assembled into ScFv DNAs with a specially constructed linker DNA by polymerase chain reaction. The ScFv DNAs were ligated into the phagemid vector pCANTAB5E and the ligated sample was transformed into competent E.coli TG1.The transformed cells were infected with M13KO7 helper phage to yield recombinant phage, which displays ScFv fragments on the surface of the filamentous phage M13. After two rounds of panning with gastric carcinoma cell line KATOⅢ highly expressing MGd1 binding antigen, the phage clones displaying ScFv of the antibody were selected by ELISA from the enriched phages. The affinity of the positive phage clones was assayed by competition ELISA. Results The VH,VL and ScFv DNAs were about 340, 320 and 750 bp respectively. 12 phage clones displaying ScFv of MGd1 were selec ted from 30 enriched phage clones. 5 of the 12 phage clones could strongly compete with the original antibody MGd1 for binding to the antigen highly expressed on KATOⅢ cells. Conclusion [WT5”,6BZ]The phage displayed ScFv of monoclonal antibody MGd1 is successfully produced by phage display technology, which may pave a way for broadening the application range of the antibody. [
出处 《免疫学杂志》 CAS CSCD 北大核心 2001年第3期165-168,共4页 Immunological Journal
基金 国家杰出青年基金! (395 2 5 0 2 0 ) 国家"86 3"课题! (10 2 - 10 - 0 1- 0 6 ) 国家自然科学基金! (3990 0 0 6 8)资助项目
关键词 胃癌 单克隆抗体 单链可变区片段 噬菌体呈现 抗MGd1 SCFV gastric carcinoma monoclonal antibody antibody single chain variable fragment phage display technology
  • 相关文献

参考文献1

  • 1Fan Daiming,J Med Coll PLA,1988年,3卷,4期,328页 被引量:1

同被引文献19

  • 1张广发,王琰,王雅明,徐建军,刘华.噬菌体抗体库的构建及抗肿瘤单抗的筛选[J].中华肿瘤杂志,1995,17(4):258-262. 被引量:13
  • 2Siegel DL. Recombinant monoclonal antibody technology[J]. Transfus Clin Biol, 2002, 9(1):15-22. 被引量:1
  • 3Reason DC, Warner TC, Lucas AH. Human Fab fragments specific for the haemophilus influenzae b polysaccharide isolated from a bacteriophage combinatorial library use variable region gene combinations and express an idiotype that mirrors in vivo expression[ 被引量:1
  • 4Marks JD, Tristem M, Karpas A, et al. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes[J]. Eur J Immunol, 1991, 21(4):985-991. 被引量:1
  • 5Persson MA, Caothien RH, Burton DR. Generation of diverse high-affinity human monoclonal antibodies by repertorire clo- ning[J]. Proc Natl Acad Sci USA, 1991, 88(6):2 432- 2 436. 被引量:1
  • 6De Haard HJ, van Neer N, Reurs A, et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies[J]. J Biol Chem, 1999, 274(26): 18 218-18 230. 被引量:1
  • 7Bradbury A , Sblattero D. Exploiting recombination in single bacteria to make large phage antibody libraries[J]. Nat Biotechnol, 2000, 18(1): 75-81. 被引量:1
  • 8Welschof M, Terness P, Kolbinger F, et al. Amino acid sequences based PCR primers for amplifyication of rearranged human heavy and light chain immuneoglobulin variable region genes[J]. J Immunol Methods,1995, 179(2):203-214. 被引量:1
  • 9Colcher D,Pavlinkova G,Beresford G,et al.Pharmacokinetics and biodistribution of genetically-engineered antibodies [J].Q J Nucl Med,1998,42(4):225-241. 被引量:1
  • 10You SY,Zhang CY,Yi XP,et al.Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin [J].Hybridoma,2001,20 (4):243-248. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部